NCT06592014
Lithium for Parkinson's: an Extension Trial
Enrolling by Invitation
PHASE1Ages 45–80InterventionalTreatmentState University of New York at BuffaloInvestigator-initiated
~35 participants
Updated 2025-11-19 on ClinicalTrials.gov
What's tested:Lithium aspartate
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Free Water
Measured over 24 Weeks.
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesNew York1
Study leadership
- Thomas Guttuso, MD · PRINCIPAL_INVESTIGATOR · University at Buffalo
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Free Water24 Weeks.
Change in MRI-assessed free water in posterior substantia nigra, dorsomedial nucleus of the thalamus and nucleus basalts of Meynert.
- Serum neurofilament light chain24 weeks
Change in serum neurofilament light chain